1. Home
  2. CGEN vs KVHI Comparison

CGEN vs KVHI Comparison

Compare CGEN & KVHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • KVHI
  • Stock Information
  • Founded
  • CGEN 1993
  • KVHI 1978
  • Country
  • CGEN Israel
  • KVHI United States
  • Employees
  • CGEN N/A
  • KVHI N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • KVHI Radio And Television Broadcasting And Communications Equipment
  • Sector
  • CGEN Health Care
  • KVHI Technology
  • Exchange
  • CGEN Nasdaq
  • KVHI Nasdaq
  • Market Cap
  • CGEN 125.3M
  • KVHI 110.2M
  • IPO Year
  • CGEN 2000
  • KVHI 1996
  • Fundamental
  • Price
  • CGEN $1.65
  • KVHI $5.78
  • Analyst Decision
  • CGEN
  • KVHI
  • Analyst Count
  • CGEN 0
  • KVHI 0
  • Target Price
  • CGEN N/A
  • KVHI N/A
  • AVG Volume (30 Days)
  • CGEN 324.9K
  • KVHI 98.7K
  • Earning Date
  • CGEN 11-10-2025
  • KVHI 11-06-2025
  • Dividend Yield
  • CGEN N/A
  • KVHI N/A
  • EPS Growth
  • CGEN N/A
  • KVHI N/A
  • EPS
  • CGEN N/A
  • KVHI N/A
  • Revenue
  • CGEN $6,903,000.00
  • KVHI $107,407,000.00
  • Revenue This Year
  • CGEN N/A
  • KVHI N/A
  • Revenue Next Year
  • CGEN $208.08
  • KVHI $14.15
  • P/E Ratio
  • CGEN N/A
  • KVHI N/A
  • Revenue Growth
  • CGEN N/A
  • KVHI N/A
  • 52 Week Low
  • CGEN $1.13
  • KVHI $4.69
  • 52 Week High
  • CGEN $2.66
  • KVHI $6.41
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 46.42
  • KVHI 53.51
  • Support Level
  • CGEN $1.54
  • KVHI $5.09
  • Resistance Level
  • CGEN $1.79
  • KVHI $5.50
  • Average True Range (ATR)
  • CGEN 0.11
  • KVHI 0.34
  • MACD
  • CGEN -0.01
  • KVHI -0.03
  • Stochastic Oscillator
  • CGEN 34.62
  • KVHI 68.87

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

Share on Social Networks: